Back to
VANGUARD GROUP INC
XERS6 quarters
Position history for
VANGUARD GROUP INC's holdings in XERIS BIOPHARMA HOLDINGS INC
As of its last 13F, for Q4 2025, Vanguard Group held 11,186,677 shares of XERS (Xeris Biopharma Holdings), worth $87.8M. It increased the position by 1,358,760 shares (+13.8%) from Q3 2025. Vanguard Group held XERS from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.
Current Value
$87.8M
Current Shares
11.2M
Total Value Change
+$65.7M
Total Shares Change
+3.4M
Quarter-by-Quarter History
Other major holders of XERS: BlackRock, Inc., D. E. Shaw & Co., Inc.